Avance Medical
Avance Medical is a small, privately held Swiss firm (1–10 employees, founded 2009) focused on the distribution, market-access, promotion, and development of autologous bio-cellular technologies, serving clinicians and institutional buyers of patient-derived cellular therapies.
- Company typePrivate
- Founded2009
- HeadquartersPayerne, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Avance Medical does
Avance Medical is a privately held Swiss company founded in 2009 and headquartered in Payerne, Switzerland. Its stated focus is the distribution, market-access, promotion, and development of autologous bio-cellular technologies — patient-derived cellular therapies in which cells are harvested from and returned to the same individual. The company operates at a micro-scale, with a reported headcount of 1–10 employees, and functions as a commercial and development intermediary between bio-cellular technology producers and the clinicians, clinics, or institutional buyers that administer such therapies.
No specific products, proprietary technologies, regulatory certifications, customer agreements, pricing structures, or partnership relationships are disclosed in the available data. The company's core technology, product catalog, revenue model, and go-to-market mechanics cannot be characterized beyond the high-level scope statement. There is no disclosed management team, no funding history, and no evidence of recent product or geographic expansion.
A material signal affecting the assessment of operational status is that the company's primary web domain (avancemedical.com) is currently listed for sale on Spaceship.com at a listed price of $4,888, with the live page replaced by a domain-sale listing rather than an active corporate site. This is a strong indicator of brand or corporate wind-down, asset disposition, or extended operational dormancy, and is the single most consequential data point for assessing current viability.
Avance Medical firmographics
Firmographics- Name
- Avance Medical
- Website
- https://avancemedical.com
- Company type
- Private
- Founded year
- 2009
- Headcount range
- 1–10 employees
- Short description
- Avance Medical is a small, privately held Swiss firm (1–10 employees, founded 2009) focused on the distribution, market-access, promotion, and development of autologous bio-cellular technologies, serving clinicians and institutional buyers of patient-derived cellular therapies.
- Ownership category
- akta.pro rank
Avance Medical industry classification
Industry- Product category
- Medical Device Distribution
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Cell Therapy Developers (Autologous) (HLAAABAA)
- akta.pro secondary industry
- Biologics & Biosimilars Distributors (HLAIAJAH)
Keywords
Where Avance Medical is headquartered
LocationHeadquarters
- HQ city
- Payerne
- HQ country
- Switzerland
- HQ region
- Europe
Markets served
Avance Medical business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain
Avance Medical product offering
Product offeringCore offering
Avance Medical specializes in the distribution, market-access, promotion and development of autologous bio-cellular technologies. The company operates as a niche player in the regenerative medicine sector, focusing on patient-derived cellular technology products. It provides distribution and commercialization services for bio-cellular technology products in the healthcare market.
Differentiator
Problem solved
Functional benefit
Products and services
- Autologous Bio-cellular Technology Distribution Distribution services for autologous bio-cellular technology products, targeting healthcare providers, clinics, and medical technology companies in the regenerative medicine sector.
- Market Access Services for Bio-cellular Products Market access services designed to help bio-cellular technology products enter and establish presence in healthcare markets, including regulatory navigation and commercialization support.
- Bio-cellular Product Promotion Promotional services for autologous bio-cellular technology products, targeting healthcare professionals and organizations in the regenerative medicine field.
- Autologous Bio-cellular Technology Development Development services for autologous bio-cellular technologies, supporting innovation and product advancement in the regenerative medicine sector.
Companies that use Avance Medical
Customer profileIdeal customer profiles1 record
Avance Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Avance Medical partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights2 records
Avance Medical competitors and assessment
Company assessmentDirect peers
- MiMedx Group: Develops and distributes placental tissue allografts for wound care and surgical applications. Comparable as a developer-distributor of bio-cellular regenerative products with a similar sales-and-market-access model.
- BioCardia: Develops autologous cell therapies for cardiovascular disease using its proprietary delivery platform. Directly comparable to Avance Medical's focus on autologous bio-cellular therapy development.
- Capricor Therapeutics: Develops cell therapy and exosome-based therapeutics (CAP-1002) for Duchenne muscular dystrophy and other indications. Comparable as an autologous/allogeneic cell therapy developer.
- Mesoblast Limited: Develops allogeneic and autologous cellular medicines for inflammatory and cardiovascular diseases. Comparable as a cell therapy developer with commercialization infrastructure targeting similar therapeutic categories.
- Vericel Corporation: Develops and commercializes autologous cell therapies (MACI, Epicel) for orthopedic and burn indications. Directly comparable to Avance Medical's stated focus on autologous bio-cellular therapy development and distribution.
- Pluristem Therapeutics: Develops placenta-derived cell therapies for hematologic, muscle, and inflammatory indications. Comparable as a bio-cellular therapy developer pursuing commercialization and distribution partnerships.
- Organogenesis Holdings: Develops and commercializes regenerative medicine products (Apligraf, Dermagraft) for wound care and surgical applications. Comparable as a vertically integrated developer-distributor of bio-cellular technologies.
Broad incumbents
- Smith & Nephew: Global medical device company with a sizable Advanced Wound Management portfolio including cellular and tissue-based products (e.g., OASIS, Grafix). Comparable as a broad incumbent with overlapping regenerative-medicine distribution and product capabilities.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights3 records
Customer concentration
Avance Medical social profiles
Digital presenceAvance Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Avance Medical leadership team
Management profileNumber of profiles
Avance Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Avance Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Avance Medical
What does Avance Medical do?
Avance Medical specializes in the distribution, market-access, promotion and development of autologous bio-cellular technologies. The company operates as a niche player in the regenerative medicine sector, focusing on patient-derived cellular technology products. It provides distribution and commercialization services for bio-cellular technology products in the healthcare market.
When was Avance Medical founded?
Avance Medical was founded in 2009. It employs 1 to 10 people.
Where is Avance Medical based?
Avance Medical is headquartered in Payerne, Switzerland, in the Europe region.
Who are Avance Medical's main competitors?
Direct peers on record are MiMedx Group, BioCardia, Capricor Therapeutics, Mesoblast Limited, Vericel Corporation, Pluristem Therapeutics and Organogenesis Holdings. Smith & Nephew is listed as a broad incumbent.
Does Avance Medical have an API?
No public API is recorded for Avance Medical.
What industry is Avance Medical in?
Avance Medical's product category is Medical Device Distribution. Its primary akta.pro industry code is HLAAABAA, Cell Therapy Developers (Autologous), with a secondary code of HLAIAJAH, Biologics & Biosimilars Distributors. Its NAICS code is 325414 and its SIC code is 2836.